SYKStryker Corporation

$138B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.2B+9.7% YoY

Gross Profit

$3.2B60.9% margin

Operating Income

$1.0B19.1% margin

Net Income

$788M15.0% margin

EPS (Diluted)

$2.05

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

$204M

Free Cash Flow

$37M

Stock-Based Comp.

$87M

Balance Sheet

Total Assets

$39.4B

Total Liabilities

$20.2B

Stockholders' Equity

$19.2B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.2B	$4.8B	+9.7%
Gross Profit	$3.2B	$2.9B	+11.3%
Operating Income	$1.0B	$858M	+16.9%
Net Income	$788M	$592M	+33.1%

Revenue Segments

MedSurg

$3.0B57%

Orthopaedics and Spine

$2.2B43%

Geographic Segments

United States

$3.9B75%

Non-US

$1.3B25%

SYK Q1 2024 Earnings — Stryker Corporation Revenue & Financial Results | Market Cap Arena